Business April 30, 2021

Covid-19 vaccine tech startup Vaccitech falls 20% in its market debut

Vaccitech plc, a biotechnology company developing vaccines and immunotherapies for diseases like cancer and hepatitis fell nearly 20% in Nasdaq,…